全球呼吸迴路市场 - 2023-2030
市场调查报告书
商品编码
1345406

全球呼吸迴路市场 - 2023-2030

Global Breathing Circuits Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球呼吸迴路市场将于 2022 年达到 12 亿美元,预计到 2030 年将达到 17 亿美元,2023-2030 年预测期间复合年增长率为 4.4%。

呼吸迴路的理想特性包括气流阻力低、先前呼出气体的再呼吸最少、以二氧化碳产生的速度去除二氧化碳、需要时输送气体成分的快速变化、吸入气体的加温加湿,并安全处置废气。

呼吸迴路的发展历史与麻醉剂和技术的进步并行。现代呼吸迴路可以根据二氧化碳吸收、阀门位置和稀释新鲜气体的使用等特征进行分类。呼吸迴路的组件包括管道、阀门、储液袋、连接器和输送组件,例如现代体积反射器。

此外,全球呼吸循环是由多种因素驱动的,例如由于有利的监管环境和不断增加的患有慢性疾病的人口,一些主要参与者正在全球范围内扩大其製造设施。呼吸功能障碍发病率的上升也将推动对呼吸迴路的需求。

动力学

呼吸道疾病患病率上升

呼吸道疾病患病率的增加是预测期内帮助市场增长的关键驱动因素之一。由于呼吸系统疾病的增加,根据疾病范围需要通气,确实需要使用呼吸迴路,这确实会增加市场的增长。

例如,根据疾病控制和预防中心的数据,慢性阻塞性肺病估计影响 2000 亿人,每年有 32 亿人死亡,使其成为全球第三大死亡原因。

哮喘是最常见的非传染性疾病之一,影响着全球 2620 亿人。预计到 2022 年,肺癌新增病例将达到近 22 亿,死亡人数将达到 18 亿,肺癌占全球癌症死亡人数的四分之一。下呼吸道感染或肺炎是一个重要的死亡原因,每年造成超过 24 亿人死亡,主要发生在低收入和中等收入国家 (LMIC)。 COVID-19 显着增加了全球肺炎死亡人数。

呼吸迴路的技术进步

呼吸迴路的技术进步是预测期内帮助市场增长的关键因素之一。最近麻醉护理方面取得了一些进展,例如直接注射挥发性麻醉剂、麻醉剂保存装置、红外低成本分析仪和闭路麻醉。

闭路系统已成为麻醉输送系统的最新改进。这些系统通过匹配患者的氧气和麻醉剂消耗来发挥作用,这与之前具有恆定低新鲜气体流量和废气清除系统的方法不同。

阻塞性睡眠呼吸暂停患病率上升

阻塞性睡眠呼吸暂停患病率的上升是预测期内市场加速增长的驱动力。例如,根据美国睡眠呼吸暂停协会的数据,仅 180 亿美国人就患有睡眠呼吸暂停。该统计数据表明,大约每 15 个美国人中就有 1 人(即美国总人口的 6.62%)患有睡眠呼吸暂停。加州大学圣地亚哥分校进行的一项研究对 54 名非裔美国人和 346 名白人进行了睡眠呼吸暂停的研究。

结果显示,17% 的非裔美国人受试者患有阻塞性睡眠呼吸暂停,而白人受试者中这一比例为 8%。这表明非裔美国人患阻塞性睡眠呼吸暂停的风险增加的假设。百分之二到百分之四的美国人患有未确诊的睡眠呼吸暂停病例。这约占每 50 人中就有 1 人未被确诊。

增加 ICU 呼吸迴路的需求

ICU 呼吸迴路需求的增加是预测期内帮助市场增长的关键因素之一。重症监护病房使用呼吸迴路来帮助患者进行呼吸过程。这些电路连接到机械呼吸机,用于向患者提供氧气并去除二氧化碳。呼吸迴路的目的是为患者提供可控且安全的气流,同时通过在呼出的空气或水分到达呼吸机之前收集其来防止感染。因此,呼吸迴路可以将富氧空气输送到患者的肺部,同时去除二氧化碳。

产品召回

产品召回是预测期内阻碍市场增长的因素之一。例如,2023 年 5 月,Draeger Medical 发现由于製造错误,粘合连接可能在通气前或通气过程中鬆动,因此召回了 Seattle PAP Plus 以及 VentStar 和其他呼吸迴路/麻醉套件。结果可能会导致包括聚水器、Y 形接头或软管连接器在内的组件部分或完全脱离。

这些部件鬆动或脱落可能会中断呼吸迴路,并可能导致严重伤害,包括缺氧(缺氧)或死亡。对于包括新生儿(新生儿)在内的重症患者来说,受伤或死亡的风险尤其大。因此,上述因素将限制市场在预测期内的增长。

此外,虽然呼吸迴路在医院、诊所、门诊手术中心和家庭护理机构中的使用不断扩大,但预计有几个问题将限制全球市场的扩张。由于单向阀和二氧化碳吸收增加,患者可能会出现呼吸困难。

目录

第 1 章:方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义和概述

第 3 章:执行摘要

  • 按产品分类的片段
  • 按应用程序片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 呼吸道疾病患病率上升
      • 呼吸迴路的技术进步
      • 阻塞性睡眠呼吸暂停患病率上升
      • 增加 ICU 呼吸迴路的需求
    • 限制
      • 产品召回
    • 机会
      • 研究与开发的崛起
    • 影响分析

第 5 章:行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章:按产品类型

  • 开放式呼吸迴路
  • 半开放式呼吸迴路
  • 半封闭呼吸系统
  • 封闭式呼吸迴路

第 8 章:按应用

  • 麻醉
  • 呼吸功能障碍
  • 其他的

第 9 章:最终用户

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第 10 章:按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Medtronic plc
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Ambu A/S
  • Flexicare Medical Ltd
  • Fisher & Paykel Healthcare Ltd
  • Dragerwerk AG & Co.
  • Hamilton Medical
  • Armstrong Medical Industries Inc
  • Meditera
  • GE Healthcare
  • Bio Med Devices

第 13 章:附录

简介目录
Product Code: MD6773

Overview

Global Breathing Circuits Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.7 billion by 2030, growing with a CAGR of 4.4% during the forecast period 2023-2030.

The desirable characteristics of a breathing circuit include low resistance to gas flow, minimal rebreathing of the preceding exhaled gases, removal of carbon dioxide at the rate at which it is produced, rapid changes in delivered gas composition when required, warmed humidification of the inspired gases, and safe disposal of waste gases.

The history of the development of breathing circuits parallels advancements in anaesthetic agents and techniques. Modern breathing circuits can be classified according to characteristics such as carbon dioxide absorption, valve position, and the use of diluting fresh gases. The components of the breathing circuit include the tubing, valves, reservoir bag, connectors, and delivery assemblies such as the modern volume reflector.

Furthermore, the global breathing circuit is driven by various factors, like several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits.

Dynamics

Rise in the Prevalence of Respiratory Diseases

Increased prevalence of respiratory disease is one the key driver that helps the market to grow during the forecast period. Since rising in respiratory diseases, the need of ventilation is required according to the disease range indeed usage of breathing circuits is needed which indeed will increase the market growth.

For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 Billion people, with 3.2 Billion dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 Billion people worldwide. With almost 2.2 Billion new instances of lung cancer expected in 2022 and 1.80 Billion fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 Billion fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Technological Advancements in Breathing Circuits

Technological advancements in breathing circuits are one of the key factors that help the market to grow during the forecast period. Several advancements have happened in anaesthesia care recently, like Direct Injection of Volatile Anesthetics, Anesthetic Agent Conserving devices, Infrared Low-Cost analyzers, and Closed-Circuit Anesthesia.

Closed-circuit systems have become the newest improvement to anaesthesia delivery systems. These systems function by matching both the oxygen and anaesthetic agent consumption of the patient, as opposed to previous methods of having a constant low fresh gas flow and scavenging system for wasted gas.

Rise in the Prevalence of Obstructive Sleep Apnea

The rise in the prevalence of obstructive sleep apnea is the driver that helps the market to accelerate during the forecast period. For instance, according to the American Sleep apnea Association Sleep apnea is prevalent in as many as 18 Billion Americans alone. This statistic denotes that approximately 1 in every 15 Americans, or 6.62% of the total American population have a case of sleep apnea. Research conducted at the University of California's San Diego campus studied 54 African Americans and 346 Caucasians for the presence of sleep apnea.

The results showed that a full 17 per cent of African American test subjects had a case of obstructive sleep apnea present, compared to 8 per cent of the Caucasian subjects. This denotes a hypothesis that African Americans stand an increased risk of obstructive sleep apnea. Two to four per cent of all Americans have an undiagnosed case of sleep apnea. This accounts for approximately 1 in 50 individuals being undiagnosed.

Increase Demand for Breathing Circuits in ICU

Increase demand for breathing circuits in ICUs is one of the key factors that helps the market to grow during the forecast period. Breathing circuits are used in intensive care units to assist patients with their respiratory processes. These circuits are connected to mechanical ventilators, which are used to supply oxygen to the patient and remove carbon dioxide. The breathing circuit's objective is to provide the patient with a regulated and secure gas flow while preventing infection by collecting any exhaled air or moisture before it reaches the ventilator. Hence The breathing circuit allows oxygen-rich air to be delivered to the patient's lungs while also removing carbon dioxide.

Product Recall

Product recall is one of the factors that hamper the market growth during the forecast period. For instance, in May 2023 Draeger Medical recalled the Seattle PAP Plus as well as VentStar and other breathing circuit/anaesthesia kits after finding that glued connections may loosen before or during ventilation due to a manufacturing error. Partial or complete detachment of components including the water trap, y-piece, or hose connector, may occur as a result.

Loosening or detachment of these parts can interrupt the breathing circuit and may cause severe injury including lack of oxygen (hypoxia) or death. The risk of injury or death is especially great for critically ill patients including newborns (neonates). Thus the above factor will restrict the market from growing during the forecast period.

Also, while the use of breathing circuits in hospitals, clinics, ambulatory surgery centres and home care settings continues to expand, several issues are expected to restrain the expansion of the market globally. Patients may experience breathing difficulty due to unidirectional valves and increasing absorption of carbon dioxide.

Segment Analysis

The global breathing circuits market is segmented based on product type, application, end user and region.

The Hospitals Segment From The End User Segment Accounted for Approximately 43.1% of the Breathing Circuits Share

The hospitals segment from the end user segment accounted for 43.1% and it is expected to be dominated during the forecast period. Hospitals are anticipated to increasingly install breathing circuits owing to a rising number of agreements with several distributors, including local and regional firms. Moreover, the presence of advanced tertiary care settings in many countries is set to aid growth. Hospitals nowadays are also striving to provide comprehensive care to patients to push the adoption of breathing circuits globally, which would drive the segment.

For instance, in December 2022, ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze Clear System. This new airway clearance system helps patients clear their airways as well as prevent or treat atelectasis by using Oscillating Lung Expansion (OLE) therapy. BiWaze® Clear can be used to treat both acute and chronic respiratory conditions in the hospital, long-term care and home environments.

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, owing to the significant presence of major market players, flourishing healthcare facilities and increasing hospitalization rates for patients with respiratory diseases.

For instance, in October 2022 Medtronic plc a global leader in healthcare technology stated that company separated its combined patient monitoring and respiratory interventions businesses ("NewCo"), which are part of the company's Medical Surgical Portfolio previously. The Respiratory Interventions technology portfolio includes Puritan Bennett ventilators, Shiley airway portfolio, McGrath MAC video laryngoscopy, DAR breathing systems, as well as PAV+, NIV+ and IE Sync ventilation software solutions designed to improve workflow and care delivery.

Furthermore, in October 2021, ARMSTRONG MEDICAL launched Aqua VENT VT heated ventilator breathing circuits. These breathing circuits are used in critical care settings for mechanical life support ventilation and have been engineered to maintain humidity within the breathing circuits in a simple manner.

Competitive Landscape

The major global players in the market include: Medtronic plc, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Ltd, Dragerwerk AG & Co, Hamilton Medical, Armstrong Medical Industries Inc, Meditera, GE Healthcare, Bio-Med Devices and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has impacted the economies of diverse countries throughout the world in three ways: directly influencing output and demand; disrupting distribution systems; and having a financial impact on corporations and financial markets. Several nations, including Thailand, Indonesia, and Singapore, are experiencing transportation and distribution issues for healthcare items.

During the COVID-19 pandemic, there was an upsurge in demand for ventilators due to their usage in COVID-19 treatment, however, there was a scarcity of ventilators. For instance, on August 26, 2022, the United States Food and Drug Administration (FDA) issued an update about a medical equipment shortage caused by the COVID-19 pandemic. The device shortage list included categories such as dialysis-related items, personal protective equipment, testing supplies and equipment, and ventilation-related products.

By Product

  • Open Breathing Circuits
  • Semi Open Breathing Circuits
  • Semi-closed breathing systems
  • Closed Breathing Circuits

By Application

  • Anaesthesia
  • Respiratory Dysfunction
  • Others

By End user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In November 2022, Xplore Health Technologies launched 'Airofit Pro' the world's first smart respiratory device which cost Rs. 34,990. The newly launched 'Airofit Pro' is a respiratory muscle training device.
  • In August 2022, Dragerwerk AG & Co. KGaA launched the Drager BG ProAir, a closed-circuit breathing device including innovative features to safeguard firemen participating in long-duration deployments, such as those in complex structures, tall buildings, tunnels, and basements.
  • In January 2022, Armstrong Medical launched its state-of-the-art heated breathing circuit technology, 'AquaVENT VT', in the Middle Eastern market. Armstrong Medical's state-of-the-art AquaVENT VT ventilator circuits manage humidity throughout the entire ventilator breathing circuit, meaning healthcare providers can focus their time on caring for their patients.

DMI Opinion

Overall, the global breathing circuit market has significant growth in future due to many factors Demand for breathing circuits will remain robust, offsetting any industry margin compression. Several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits. Hence also in the future upcoming innovations in the ventilation system and a rise in research and development will help the breathing circuit market to accelerate in future with utmost advancements.

Why Purchase the Report?

  • To visualize the global breathing circuits market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global breathing circuits market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global breathing circuits market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Respiratory Diseases
      • 4.1.1.2. Technological Advancements in Breathing Circuits
      • 4.1.1.3. Rise in the Prevalence of Obstructive Sleep Apnea
      • 4.1.1.4. Increase Demand for Breathing Circuits in ICU
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recall
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in Research and Developments
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Open Breathing Circuits*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Semi Open Breathing Circuits
  • 7.4. Semi-closed breathing systems
  • 7.5. Closed Breathing Circuits

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Anesthesia*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Respiratory Dysfunction
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Ambu A/S
  • 12.3. Flexicare Medical Ltd
  • 12.4. Fisher & Paykel Healthcare Ltd
  • 12.5. Dragerwerk AG & Co.
  • 12.6. Hamilton Medical
  • 12.7. Armstrong Medical Industries Inc
  • 12.8. Meditera
  • 12.9. GE Healthcare
  • 12.10. Bio Med Devices

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us